-51.5%
GLXY vs GSK
+9.8%
-61.2%
-62.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.9% | +0.1% | -5.0% | -4.9% |
| 7D | +16.9% | +0.5% | +16.5% | +17.2% |
| 30D | -23.0% | +9.4% | -32.4% | -18.9% |
| 3M | -28.0% | +1.6% | -29.6% | -25.9% |
| 6M | -51.6% | +1.3% | -52.9% | -50.2% |
| YTD | -32.1% | +6.0% | -38.1% | -23.0% |
| 1Y | -51.5% | +9.1% | -60.5% | -44.6% |
| All | -51.5% | +9.8% | -61.2% | -44.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling